AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2025
Mar 13, 2025
31660_dirs_2025-03-12_c23a3a69-3b4c-4b67-8bb8-e2da53cd7814.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2025-03-10
Reporting Person: NEUPERT PETER M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-10 | Common Stock | M | 50000 | $4.07 | Acquired | 234690 | Direct |
| 2025-03-10 | Common Stock | S | 10000 | $7.05 | Disposed | 224690 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-10 | Stock Option (right to buy) | $4.07 | M | 50000 | Disposed | 2025-03-31 | Common Stock (50000) | Direct |
Footnotes
F1: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.03 to 7.07, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
F2: The option was fully vested and exercisable.